The efficient spread of malaria from infected humans to mosquitoes is a major challenge for
malaria elimination initiatives. Gametocytes are the only Plasmodium life stage infectious to …

Human and animal pathogens that are transmitted by arthropods are a global concern,
particularly those vectored by ticks (eg Borrelia burgdorferi and tick-borne encephalitis virus) …

Summary Pfs230 domain 1 (Pfs230D1) is an advanced malaria transmission-blocking
vaccine antigen demonstrating high functional activity in clinical trials. However, the …

Malaria transmission-blocking vaccines (TBVs) reduce disease transmission by breaking the
continuous cycle of infection between the human host and the mosquito vector. Domain 1 …

Malaria transmission-blocking vaccines (TBVs) target the development of Plasmodium
parasites within the mosquito, with the aim of preventing malaria transmission from one …

Recently, there has been a renewed interest in the development of transmission-blocking
vaccines (TBV) against Plasmodium falciparum malaria. While several candidate TBVs have …

Malaria transmission-blocking vaccines (TBV) targeting sexual stages of the parasite
represent an ideal intervention to reduce the burden of the disease and eventual elimination …

Development of a Plasmodium falciparum (Pf) transmission blocking vaccine (TBV) has the
potential to significantly impact malaria control. Antibodies elicited against sexual stage …

Animal and human pathogens that are transmitted by arthropods are a global concern,
particularly those vectored by mosquitoes (eg, Plasmodium spp. and dengue virus). Vector …

The Plasmodium falciparum Pf s230 and Pf s48/45 proteins are expressed during
transmission from man to mosquito and are leading candidates for a malaria transmission …